New Zealand markets closed

Vaxxinity, Inc. (VAXX)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0900+0.0100 (+12.50%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.41M
Enterprise value -3.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.76
Enterprise value/revenue -199.98k
Enterprise value/EBITDA -1.98

Trading information

Stock price history

Beta (5Y monthly) 2.80
52-week change 3-94.94%
S&P500 52-week change 326.94%
52-week high 33.1000
52-week low 30.0450
50-day moving average 30.3533
200-day moving average 30.9077

Share statistics

Avg vol (3-month) 32.26M
Avg vol (10-day) 3800.14k
Shares outstanding 5112.91M
Implied shares outstanding 6126.78M
Float 855.6M
% held by insiders 150.71%
% held by institutions 110.86%
Shares short (15 Apr 2024) 44.22M
Short ratio (15 Apr 2024) 413.97
Short % of float (15 Apr 2024) 4108.73%
Short % of shares outstanding (15 Apr 2024) 43.33%
Shares short (prior month 15 Mar 2024) 43.85M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-48.34%
Return on equity (ttm)-150.65%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -56.05M
Net income avi to common (ttm)-56.93M
Diluted EPS (ttm)-0.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.64M
Total cash per share (mrq)0.24
Total debt (mrq)15.17M
Total debt/equity (mrq)113.12%
Current ratio (mrq)1.89
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-57.24M
Levered free cash flow (ttm)-37.38M